Overview

* ProAssurance ( PRA ) Q2 net income beats analyst expectations, per LSEG data

* Adjusted operating income for Q2 exceeds estimates, per LSEG data

* Co's merger with The Doctors Company approved by stockholders, FTC grants early termination

Outlook

* Company anticipates merger with The Doctors Company to close in H1 2026

* ProAssurance ( PRA ) focuses on disciplined underwriting and cost management

Result Drivers

* STABLE PREMIUMS - Medical Professional Liability segment maintained stable net premiums, offset by declines in other lines

* RATE INCREASES - Specialty P&C renewal premiums increased by 10%, contributing to a cumulative premium change of over 70% since 2018

* RESERVE DEVELOPMENT - Improved combined ratios largely due to favorable prior year reserve development

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q2 Gross $216.93

Premiums mln

Q2 Net Beat $21.92 $10.20

Income mln mln (3

Analysts

)

Q2 Beat $26.77 $8.09

Adjusted mln mln (1

Operatin Analyst)

g Income

Q2 Beat $27.44 $10.30

Pretax mln mln (1

Profit Analyst)

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"

* The average consensus recommendation for the property & casualty insurance peer group is "buy."

* Wall Street's median 12-month price target for ProAssurance Corp ( PRA ) is $25.00, about 4.8% above its August 4 closing price of $23.80

* The stock recently traded at 25 times the next 12-month earnings vs. a P/E of 24 three months ago

Press Release:

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)